A0613 Celecoxib combined with low-dose-rate brachytherapy improves long-term metastasis-free rate in non-metastatic prostate cancer: 10-year post-hoc randomized study

European Urology 2026

View at publisher

Authors: Y. Nakai, N. Tanaka, K. Onishi, K. Yamaki, K. Fujimoto

DOI: 10.1016/s0302-2838(26)00664-0

Cited by: 0

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Inflammatory mediators and NSAID effects